Characterization of aromatase and 17β-hydroxysteroid dehydrogenase expression in rat osteoblastic cells

Journal of Bone and Mineral Research

Volumn 13, Issue 6, 1998, Pages 996-1004

  Eyre, Louise J ^a   Bland, Rosemary ^a   Bujalska, Iwona J ^a   Sheppard, Michael C ^a   Stewart, Paul M ^a   Hewison, Martin ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; AROMATASE; CALCITRIOL; DEXAMETHASONE; ESTRADIOL; ESTRONE; MESSENGER RNA; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ANIMAL CELL; AROMATIZATION; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; RAT;

17-HYDROXYSTEROID DEHYDROGENASES; ANDROSTENEDIONE; ANIMALS; AROMATASE; BLOTTING, NORTHERN; CELL DIFFERENTIATION; ESTRADIOL; ESTRONE; ISOENZYMES; OSTEOBLASTS; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER; TESTOSTERONE; TUMOR CELLS, CULTURED;

EID: 0031801531     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.6.996     Document Type: Article

References (41)

1. Raisz LG 1996 The interaction of local and systemic factors in the pathogenesis of osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds.) Osteoporosis. Academic Press, San Diego, CA, U.S.A., pp. 661-670.
2. Ernst M, Schmid C, Froesch ER 1988 Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA 85:2307-2310.
3. Gray TK, Flynn TC, Gray KM, Nabell LM 1987 17-Beta-estradiol acts directly on the clonal osteoblastic cell-line UMR106. Proc Natl Acad Sci USA 84:6267-6271.
4. Jilka RL, Hangoc G, Girasole G, Passerid G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88-92.
5. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 2:1132-1136.
6. Nawata H, Tanaka S, Tanaka S, Takayanagi R, Sakai Y, Yanase T, Ikuyama S, Haji M 1995 Aromatase in bone cell: Association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 53:165-174.
7. Schweikert H-U, Wolf L, Romalo G 1995 Oestrogen formation from androstenedione in human bone. Clin Endocrinol 43:37-42.
8. Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O, Harada N 1997 Aromatase in bone. J Bone Miner Res 12:1416-1423.
9. 3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts. Endocrinology 137:1860-1869.
10. Krozowski Z 1994 The short-chain alcohol dehydrogenase superfamily: Variations on a common theme. J Steroid Biochem Mol Biol 51:125-130.
11. Adamski J, Normand T, Leenders F, Monte D, Begue A, Stehelin D, Jungblut PW, de Launoit Y 1995 Molecular cloning of a novel widely expressed human 80kDa 17β-hydroxysteroid dehydrogenase IV. Biochem J 311:437-443.
12. Peltoketo H, Isomaa V, Poutanen M, Vihko R 1996 Expression and regulation of 17β-hydroxysteroid dehydrogenase type 1. J Endocrinol 150 (Suppl):S21-S30.
13. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S 1993 Expression cloning and characterisation of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J Biol Chem 268:12964-12969.
14. Luu-The V, Zhang Y, Poirere D, Labrie F 1995 Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: Oxidation/reduction and inhibition. J Steroid Biochem Mol Biol 55:581-587.
15. Carstensen JF, Tesdorpf JG, Kaufmann M, Markus MM, Husen B, Leenders F, Jakob F, de Launoit Y, Adamski J 1996 Characterization of 17 beta-hydroxysteroid dehydrogenase IV. J Endocrinol 150 (Suppl):S3-S12.
16. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Grahamlorence S, Amarneh B, Ito YJ, Fisher CR, Michael MD, Mendelson CR, Bulun SE 1994 Aromatase cytochrome-P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15:342-355.
17. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG, Nagura H 1996 Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. Clin Endocrinol Metab 81:4042-4046.
18. Toda K, Simpson ER, Mendelson CR, Shizuta Y, Kilgore MW 1994 Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues. Mol Endocrinol 8:210-217.
19. Horton R, Tait JF 1967 In vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone in man. J Clin Endocrinol Metab 27:79-88.
20. Shozu M, Bulun SE, Zhao Y, Simpson ER 1997 Expression of a novel exon I of the aromatase gene: Exon 1.6. Endocrine Society Abstracts. The Endocrine Society, Bethesda, MD, U.S.A., abstract 417, p. 238.
21. 3, and retinoid signaling. Endocrinology 135:2375-2385.
22. Davis VL, Couse JF, Gray TK, Korach KS 1994 Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. J Bone Miner Res 9:983-991.
23. 3 and thyroid hormone in three osteosarcoma cell lines. Endocrinology 136:4304-4314.
24. 3 receptor-like macromolecule in rat osteogenic sarcoma cell lines. J Biol Chem 255:4414-4417.
25. Bland R, Sammons RL, Sheppard MC, Williams GR 1997 Thyroid hormone, vitamin D and retinoid receptor expression and signalling in primary cultures of rat osteoblastic and immortalised osteosarcoma cells. J Endocrinol 154:63-74.
26. Gray C, Colston KW, Mackay AG, Taylor ML, Arnett TR 1992 Interaction of androgen and 1,25-dihydroxyvitamin D3: Effects on normal rat bone cells. J Bone Miner Res 7:41-46.
27. Inano H, Tamaoki B 1986 Testicular 17β-hydroxysteroid dehydrogenase: Molecular properties and reaction mechanism. Steroids 48:2-26.
28. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, Elliston KO, Wilson JD, Russell DW, Andersson S 1994 Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat Genet 7:34-39.
29. Vanderschueren D, Bouillon R 1995 Androgens and bone. Calcif Tissue Int 56:341-346.
30. Orwoll ES 1996 Androgens as anabolic agents for bone. Trends Endocrinol Metab 7:77-84.
31. Kasperk CH, Wakley GK, Hierl T, Ziegler R 1997 Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res 12:464-471.
32. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ 1989 Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124:1576-1578.
33. Mason RA, Morris HA 1997 Effects of dihydrotestosterone on bone biochemical markers in sham and oophorectomized rats. J Bone Miner Res 12:1431-1437.
34. Kasperk C, Fitzsimmons R, Strong D, Mohan S, Jennings J, Wergcdal J, Baylink D 1990 Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 71:1322-1329.
35. Wiren KM, Zhang X, Chang C, Keenan E, Orwoll ES 1997 Transcriptional up-regulation of the human androgen receptor by androgen in bone cells. Endocrinology 138:2291-2300.
36. Orwoll ES, Stribrska L, Ramsey EE, Keenan EJ 1991 Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 49:183-187.
37. Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE 1997 The localization of androgen receptors in human bone. J Clin Endocrinol Metab 82:3493-3497.
38. Nakano Y, Morimoto I, Ishida O, Fujihira T, Mizokami A, Tanimoto A, Yanagihara N, Izumi F, Eto S 1994 The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells. Bone Miner 26:245-259.
39. Wink CS, Felts WJL 1980 Effects of castration on the bone structure of male rats: A model for osteoporosis. Calcif Tissue Int 32:77-82.
40. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, Manolagas SC 1995 Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens: The role androgen receptor. J Clin Invest 95:2886-2295.
41. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC 1997 The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology 138:4013-4021.